Liberum
MENU

News

Liberum appointed as Nomad and Sole Corporate Broker to Park Group plc

11 June 2019 | Sole Bookrunner

ParkG

Park Group plc (“Park Group” or the “Company”) is one of the UK’s leading multi-retailer voucher and prepaid gift card businesses, focused on the corporate gift and Christmas savings markets. Park Group plc is quoted on AIM.

Park Group generates income from service fees paid by retailers (175 brands), corporates (34,601 clients), and non-corporates in addition to interest on cash balances.

In December 2018, Park Group’s new management team announced a revised strategy focused on a simplified product range, being easier to work with for all its customers (consumers, businesses and retailers), broadening the Group’s customer appeal to drive growth and being more efficient and effective – the Group is moving offices to Liverpool City Centre during late summer of 2019 which will enable the optimal use of its assets and help it to attract talent.

The Company was founded in 1967 and was admitted to trading on AIM in 2007.

Liberum has been appointed as Nomad and Sole Corporate Broker with immediate effect.

Liberum Team

Investment Banking – Richard Crawley, Jamie Richards, Jonathan Wilkes-Green, Laura Hamilton

Research - Sanjay Vidyarthi

Sales – Oliver Baxendale

Corporate Access – Natalie Clarke

Twitter@LiberumToday

LinkedInLiberum

Liberum appointed Joint Corporate Broker to Malin Corporation Plc

05 June 2019 |

Malin2

Liberum is pleased to announce its appointment as Joint Corporate Broker to Malin Corporation Plc.

Malin invests in and supports life sciences companies developing science and technology to deliver transformative outcomes for patients and create value for shareholders.

The company focuses on oncology, immunology and genetic diseases where they believe innovative life science and healthcare technologies will deliver transformative treatments for patients.

Malin raised €330m in 2015 through its IPO on the European Securities Market of Euronext Dublin (”ESM”).

Liberum has been appointed as the Company’s Joint Corporate Broker alongside Davy, Malin’s current ESM adviser and broker.

Liberum Team

Investment Banking - Bidhi Bhoma, Euan Brown, Laura Hamilton

Research - Alistair Campbell, Graham Doyle

Sales - Lisa Tugwell

Twitter@LiberumToday

LinkedInLiberum

Liberum acts as Sole Bookrunner on £78m fundraising for Real Estate Credit Investments Limited

31 May 2019 | Sole Bookrunner

RECI

We are pleased to announce that Liberum acted as Sole Bookrunner on a Placing to raise £78m for Real Estate Credit Investments through the issue of 45,882,353 shares at 170p.

The proceeds of the placing are to be invested in debt secured by commercial or residential properties in the United Kingdom and Western Europe. RECI is a closed-ended investment company, externally managed by Cheyne Capital Management (UK) LLP. To achieve their investment objective of attractive and stable returns, primarily in the form of quarterly dividends, the Company invests in real estate credit secured by commercial or residential properties in the United Kingdom, France and Germany.

As at April 30 2019, RECI had an investment portfolio of 49 positions, with a value of £312m.

Liberum Team

Board  Shane Le Prevost

Investment Banking  Richard Crawley, Richard Bootle, William Hall, Laura Hamilton

General Counsel – Rebecca Gordon 

Sales  Andrew Davies, Anastasia Mikhailova, Jack Kershaw

Research  Conor Finn

Corporate and Investor Relations – Natalie Clarke

Twitter@LiberumToday

LinkedInLiberum

Liberum appointed Nomad and Sole Corporate Broker to Futura Medical

24 May 2019 | Corporate Broker

FM

Liberum is pleased to announce its appointment as Nomad and Sole Broker to Futura Medical plc.

Futura Medical is a pharmaceutical company with a pipeline of transdermal delivery products in late stage development. The company’s lead product is MED2005, a topical treatment for erectile dysfunction currently in Phase 3 clinical trial. The company was founded in 1997 and was admitted to trading on AIM in 2003.

Liberum has been appointed as Nomad and Sole Broker with immediate effect.

Liberum Team

Board – David Parsons

Investment Banking – Bidhi Bhoma, Euan Brown, Kane Collings

Research – Graham Doyle, Alistair Campbell

Sales – Lisa Tugwell, Oliver Baxendale, Julian Collett

Corporate and Investor Relations – Natalie Clarke

Twitter@LiberumToday

LinkedInLiberum

Liberum acts as Sole Sponsor and Joint Bookrunner on the Sirius Minerals Plc $425m Firm Placing, Placing and Open Offer as part of the Company’s $3.8bn financing plan

23 May 2019 | Joint Bookrunner

SM

We are pleased to announce that Liberum acted as Sole Sponsor and Joint Bookrunner on a Firm Placing and Placing and Open Offer to raise approximately $425m (£327m) for Sirius Minerals, which completed today. In addition, the Company raised a further $400m through the issue of convertible bonds, raising total gross proceeds of $825m. J.P. Morgan Cazenove (JPM) acted as Sole Global Coordinator and Joint Bookrunner alongside Liberum on the Firm Placing and Placing and Open Offer and Sole Bookrunner on the Convertible Bond Offering

Sirius Minerals Plc is focused on the development of the Woodsmith Mine, which will access the world's largest and highest grade polyhalite deposit located in North Yorkshire, United Kingdom. Polyhalite is a unique multi-nutrient fertilizer, which can be used to increase balanced fertilization around the world.

The placing and convertible bond offering is part of a larger $3.8bn financing plan, which includes a $2.5bn RCF facility provided by JPM and a $500m high yield bond issue to be completed during the summer of 2019.

Shares were priced at 15p. The oversubscribed placing attracted strong support from high quality existing and new investors. Sirius Minerals intends to use the proceeds from the fundraise to continue the construction of their Woodsmith Mine.

Liberum was appointed as Joint Corporate Broker to Sirius Minerals in June 2011 and has helped raise over $1bn (£810m) over 5 transactions.

Liberum Team

Board – David Parsons

Investment Banking – Clayton Bush, Richard Bootle, Edward Thomas, Trystan Cullen, William Hall

Research – Richard Knights

Sales – Sebastian Fernandez, Julian Collett, Edward Blair, Lisa Tugwell

Corporate and Investor Relations – Lynsey Cox, Marcio Remedios

Twitter@LiberumToday

LinkedInLiberum

Liberum acts as Joint Bookrunner to Brewin Dolphin on £60m fundraising

14 May 2019 | Joint Bookrunner

Bd

We are pleased to announce that Liberum acted as Joint Bookrunner on a Placing to raise £60m for Brewin Dolphin. RBC acted as Joint Bookrunner alongside Liberum and Rothschild & Co acted as Financial Adviser.

Brewin Dolphin is a private client wealth manager with an office network across the UK. It offers services to retail clients and charities, including discretionary and advisory wealth management as well as an execution-only service.

Brewin Dolphin has invested circa £70 million in inorganic growth initiatives comprising i) the acquisition of the wealth management operations of Investec Group in the Republic of Ireland; ii) the acquisition of the business and assets of Epoch Wealth Management LLP; iii) the acquisition of three other smaller businesses; and iv) new strategic organic initiatives - including 1762 and WealthPilot.

The Placing was undertaken to maintain a strong regulatory capital level for the Group, providing it with continued financial flexibility for further development opportunities.

Liberum Team

Board – David Parsons

Investment Banking – Richard Crawley, Cameron Duncan, Jonathan Wilkes-Green, Ed Phillips

Research – Ben Williams

Sales – Steve Keeling, Julian Collett, Oliver Baxendale, Lisa Tugwell

General Counsel – Rebecca Gordon

Corporate and Investor Relations – Natalie Clarke

Twitter@LiberumToday

LinkedInLiberum